Ira S Strassberg's Net Worth
$0
Who is Ira S Strassberg?
Ira S Strassberg does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Continental Building Products, Inc., and NRX Pharmaceuticals, Inc..
SEC CIK
Ira S Strassberg's CIK is 0001699729
Past Insider Trading and Trends
2017 was Ira S Strassberg's most active year for acquiring shares with 1 total transactions. Ira S Strassberg's most active month to acquire stocks was the month of January. 2020 was Ira S Strassberg's most active year for disposing of shares, totalling 2 transactions. Ira S Strassberg's most active month to dispose stocks was the month of January. 2019 saw Ira S Strassberg paying a total of $0.00 for 2,850 shares, this is the most they've acquired in one year. In 2020 Ira S Strassberg cashed out on 10,298 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Continental Building Products, Inc. No price found
InvestorIra S Strassberg used to own units in Common Stock but no longer holds any shares there.acquired a total of 10,298 shares in Continental Building Products, Inc., Ira also disposed a total of 10,298 shares of Continental Building Products, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.30K |
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +28.71% | 2.3K |
—
|
—
| 10.3K |
Jan 13
| |||
Form 4
| +55.33% | 2.85K |
—
|
—
| 8K |
Feb 20
| |||
Form 4
| +105.96% | 2.65K |
—
|
—
| 5.15K |
Feb 21
| |||
Form 4
|
∞
| 2.5K |
—
|
—
| 2.5K |
Mar 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NRX Pharmaceuticals, Inc. (NRXP) Snapshot price: $1.6
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||